# OnCo record neo-comprehensive (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/neo-comprehensive/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "neo-comprehensive" ;
  schema:name "Neo Comprehensive"@en ;
  schema:alternateName "NeoGenomics Neo Comprehensive"@en, "Neo Comprehensive - Heme Cancers"@en, "Neo Comprehensive - Myeloid Disorders"@en, "Neo Comprehensive" ;
  schema:description "NeoGenomics' gene panels for leukaemia, lymphoma and related blood cancers, reading DNA and RNA in one test."@en ;
  schema:url <https://onco.cc/drugs/neo-comprehensive/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.neogenomics.com/providers/oncology-solutions/hematological-cancer> ;
  onco:status "established" ;
  onco:tag "test" ;
  onco:modality "Genomic profiling tests for blood cancers (DNA and RNA sequencing)" ;
  onco:related <https://onco.cc/biomarkers/idh1-r132/>, <https://onco.cc/biomarkers/idh2-mutation/>, <https://onco.cc/biomarkers/flt3-itd/>, <https://onco.cc/biomarkers/flt3-tkd/>, <https://onco.cc/biomarkers/npm1-mutation/>, <https://onco.cc/biomarkers/kit-d816v/>, <https://onco.cc/biomarkers/tp53-del17p/> ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/reference-laboratories/> ;
  onco:companies <https://onco.cc/companies/neogenomics/> ;
  onco:pathways <https://onco.cc/pathways/clonal-haematopoiesis/> ;
  onco:terms <https://onco.cc/terms/ngs/> .